Clinical Trials

The PHocus Study is a Global Phase 2 clinical trial evaluating an investigational drug called mosliciguat as a potential option to treat pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).

To find out more, contact clinicaltrials@pulmovant.com.